article thumbnail

Driving efficiency across upstream bioprocess workflow

Drug Target Review

He has a post-doctorate in virology, viral pathogenesis, viral vector development, and vaccines evaluation from Harvard Medical School, and a PhD in virology/molecular biology. Anis also serves on the scientific and editorial advisory board of Genetic Engineering News at Mary Ann Liebert, Inc.

article thumbnail

Battling antibiotic resistance in the lab and the clinic

Broad Institute

He majored in biological chemistry at the University of Chicago and during his junior year, he had a fortuitous meeting with his academic advisor about finding a student research position that would let him dive more deeply into the molecular details of biological systems. A combined MD/PhD program offered both opportunities.

Hospitals 137
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Low oxygen levels restore balance and coordination in a mouse model of a movement disorder

Broad Institute

said Vamsi Mootha , senior author of the study, an institute member at the Broad, professor of systems biology and medicine at Harvard Medical School, and professor of molecular biology at Massachusetts General Hospital.

article thumbnail

Mediating BRAF-mutant melanoma resistance

Drug Target Review

She went on to an internship in internal medicine at Yale-New Haven Hospital and a residency in dermatology at Harvard Medical School. She moved to Johns Hopkins in 1999 as an Assistant Professor of Oncology, Dermatology, and Molecular Biology and Genetics and was promoted to Associate Professor in 2004.

article thumbnail

A surprising new role for a major immune regulator

Broad Institute

Now, a team of MIT, Massachusetts General Hospital (MGH), Broad Institute of MIT and Harvard, and Harvard Medical School (HMS) researchers has discovered how STING activates those two pathways. Paper Cited Liu B, Carlson R, et al. Human STING is a proton channel. Online August 3, 2023.

article thumbnail

Advancing CAR-T therapy: how CD5 modulation is shaping cancer treatment

Drug Target Review

Dr Siciliano received a BS in chemistry from Villanova University and shortly thereafter began his scientific career in the Department of Microbiology at the University of Pennsylvania Medical School studying host-pathogen interactions.

article thumbnail

Navigating the challenges of cell therapies

Drug Target Review

in Chemistry from Villanova University and shortly thereafter began his scientific career in the Department of Microbiology at the University of Pennsylvania Medical School studying host-pathogen interactions. Dr Siciliano received a B.S. He then earned a Ph.D.

Therapies 116